Antimicrobial prophylaxis in orthopedic surgery

Orthopedics

Volumn 28, Issue 8, 2005, Pages 749-751

  Morita, Kazumi ^a   Smith, Kelly M ^a,b  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC; CEFAZOLIN; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; GENTAMICIN; PENICILLIN DERIVATIVE; VANCOMYCIN;

ANAEROBIC BACTERIUM; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL ENDOCARDITIS; BACTERICIDAL ACTIVITY; COLITIS; CONSENSUS; DOSE RESPONSE; DRUG ADMINISTRATION ROUTE; DRUG BLOOD LEVEL; DRUG CHOICE; DRUG COST; DRUG CROSS REACTIVITY; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG INDICATION; DRUG SAFETY; DRUG USE; GRAM NEGATIVE BACTERIUM; HEALTH CARE COST; HIGH RISK PATIENT; HUMAN; HYPOPROTHROMBINEMIA; INFECTION PREVENTION; INFECTION RISK; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORBIDITY; NONHUMAN; ORTHOPEDIC SURGERY; POSTOPERATIVE INFECTION; PROSTHESIS INFECTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; SURGICAL INFECTION; SURGICAL MORTALITY; TIME; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; BACTERIAL INFECTIONS; HUMANS; ORTHOPEDIC PROCEDURES; RISK FACTORS; TIME FACTORS; WOUNDS AND INJURIES;

EID: 23844443528     PISSN: 01477447     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Commission on Therapeutics: ASHP Therapeutic Guidelines on Antimicrobial Prophylaxis in Surgery. American Society of Health-System Pharmacists. Am J Health Syst Pharm. 1999; 56:1839-1888.
2. Bratzler DW, Houck PM, Richards C, et al. Use of antimicrobial prophylaxis for major surgery: baseline results from the National Surgical Infection Prevention Project. Arch Surg. 2005; 140:174-182.
3. Berard F, Gandon J. Postoperative wound infections. The influence of ultraviolet irradiation of the operating room and of various other factors. Ann Surg. 1964; 160(suppl 1):1-192.
4. Devlin JW, Kanji S, Janning SW, et al. Antimicrobial prophylaxis in surgery. In: Dipiro JT, Talbert RL, Matzke GR, Posey LM, Schwinghammer TL, ed. Pharmacotherapy: A Pathophysiologic Approach. 5th ed. Stamford, Conn: Appleton & Lange; 2002:2111-2122.
5. Gorbach SL, Condon RE, Conte JE Jr, Kaiser AB, Ledger WJ, Nichols RL. Evaluation of new anti-infective drugs for surgical prophylaxis. Infectious Disease Society of America and the Food and Drug Administration. Clin Infect Dis. 1992; 15(suppl 1):S313-S338.
6. Dellinger EP, Gross PA, Barrett TL, et al. Quality Standard for Antimicrobial Prophylaxis in Surgical Procedures. The Infectious Diseases Society of America. Clin Infect Dis. 1994;18: 422-427.
7. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for Prevention of Surgical Site Infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Am J Infect Control. 1999; 27:97-132.
8. Forse RA, Karam B, MacLean LD, Christou NW. Antibiotic prophylaxis for surgery in morbidly obese patients. Surgery. 1989; 106:750-757.
9. Bratzler DW, Houck PM; Surgical Infection Prevention Guidelines Writers Workgroup, et al. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis. 2004; 38:1706-1715.
10. Dancer SJ. The problem with cephalosporins. J Antimicrob Chemother. 2001; 48:463-478.
11. Kishiyama JL, Adelman DC. The cross-reactivity and immunology of beta-lactam antibiotics. Drug Saf. 1994; 10: 318-327.
12. Cohen J, Powderly WG. Infectious Diseases. 2nd ed. Elsevier; 2004.
13. Diekema DJ, BootsMiller BJ, Vaughn TE, et al. Antimicrobial resistance trends and outbreak frequency in United States hospitals. Clin Infect Dis. 2004; 38:78-85.
14. Nosocomial enterococci resistant to vancomycin - United States, 1989-1993. MMWR Morb Mortal Wkly Rep. 1993; 42: 597-599.
15. Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR. 1994; 44:1-13.
16. Dajani AS, Thubert KA, Wilson W, et al. Prevention of bacterial endocarditis. Recommendations by the American Heart Association. JAMA. 1997; 277:1794-1801.
17. Classen DC, Evans RS, Pestotnik SL, et al. The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. New Eng J Med. 1992; 326:281-286.
18. McDonald M, Grabsch E, Marshall C, Forbes A. Single- versus multiple-dose antimicrobial prophylaxis for major surgery: a systematic review. Aust N Z J Surg. 1998; 68:388-396.